Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes

Nat Commun. 2025 May 6;16(1):4206. doi: 10.1038/s41467-025-58678-6.

Abstract

Given their rarity and diversity, a fundamental understanding of the genomic underpinnings for many sarcoma subtypes is still lacking. To better define the molecular landscape of this group of diseases, we perform matched whole exome sequencing and RNA sequencing on a cohort of 1340 sarcoma tumor specimens. We identify recurrent somatic mutations and observe an increased mutational burden in metastatic vs. primary samples (p < 0.001). We observe frequent copy number alterations including whole genome doubling, with this feature being more common in metastatic tumors (p = 0.026). Estimation of immune cell abundances followed by hierarchical clustering identifies five immune subtypes ranging from low to high and we observe inferior overall survival in immune deplete clusters compared to immune enriched (p < 0.01). Interestingly, GIST predominantly form a distinct "immune intermediate" cluster that is marked by a specific enrichment for NK cells (FDR < 0.01).

MeSH terms

  • DNA Copy Number Variations
  • Exome Sequencing
  • Female
  • Gene Expression Profiling
  • Genomics
  • Humans
  • Killer Cells, Natural / immunology
  • Male
  • Mutation
  • Sarcoma* / genetics
  • Sarcoma* / immunology
  • Sarcoma* / pathology
  • Transcriptome*